Torrent Pharmaceuticals Limited has announced a series of significant financial decisions following its board meeting held on 22 May 2026. The company has approved its audited financial results for the quarter and year ended 31 March 2026, which are available on its official website.
In a key development, Torrent Pharmaceuticals has recommended seeking shareholder approval for the issuance of equity shares, including convertible bonds or debentures, through Qualified Institutional Placement (QIP) or other methods. The proposed issuance aims to raise an amount not exceeding ₹ 5,000 crores. This proposal will be presented at the upcoming Annual General Meeting (AGM) for approval.
Additionally, the board has recommended a final dividend of ₹ 9 per equity share, equivalent to 180% of the face value of ₹ 5 each. If approved by shareholders, the dividend is expected to be paid on or around 25 June 2026. This follows an interim dividend of ₹ 29 per share, which was disbursed in the last quarter.
The company has set 29 May 2026 as the record date for determining eligible shareholders for the final dividend. Shareholders whose names appear on the Register of Members or in the records of National Securities Depositories Limited or Central Depositories Services (India) Limited as of this date will be entitled to receive the dividend.
The board meeting, which commenced at 2:00 pm and concluded at 4:00 pm, also included the release of a press statement detailing the financial results, which will be shared with the media.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).